Clinical Trials on Neoplasms, Plasma Cell in Australia
Total 4910 results
-
Provectus Biopharmaceuticals, Inc.Active, not recruitingNeuroendocrine Tumors Metastatic to the LiverAustralia
-
IpsenTerminated
-
Peter MacCallum Cancer Centre, AustraliaRecruitingMantle Cell Lymphoma RefractoryAustralia
-
Bristol-Myers SquibbCompletedNon-Small Cell Lung CancerAustralia
-
Iksuda Therapeutics Ltd.RecruitingFollicular Lymphoma | B-cell Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | B-cell Non-Hodgkin LymphomaAustralia, Canada, United States
-
RemeGen Co., Ltd.RecruitingMelanoma | Renal Cell Carcinoma | Non-small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Urothelial Carcinoma | Colorectal CarcinomaAustralia, China
-
CelgeneActive, not recruitingMultiple MyelomaAustria
-
Austrian Forum Against CancerCompletedMultiple MyelomaAustria, Czech Republic
-
Melanoma Institute AustraliaRecruitingSkin Cancer | Basal Cell Carcinoma | Invasive Carcinoma | Basal Cell Carcinoma of Skin, Site UnspecifiedAustralia
-
Novartis PharmaceuticalsActive, not recruitingMultiple MyelomaUnited States, Singapore, Israel, Australia
-
Trans Tasman Radiation Oncology GroupCompletedMetastatic Non Small Cell Lung CancerSingapore, Australia
-
Olivia Newton-John Cancer Research InstituteMerck Sharp & Dohme LLC; ViralyticsActive, not recruiting
-
Taunton and Somerset HospitalCompleted
-
Novartis PharmaceuticalsCompletedLymphoma | Leukemia | Multiple MyelomaUnited States, Germany, Australia
-
Human Genome Sciences Inc.CompletedMultiple MyelomaUnited States, Canada, Australia, India
-
Australian and New Zealand Urogenital and Prostate...Bristol-Myers SquibbActive, not recruitingRenal Cell Carcinoma | Sarcomatoid Renal Cell Carcinoma | Papillary Renal Cell Carcinoma Type 1 | Papillary Renal Cell Carcinoma Type 2 | Chromophobe Renal Cell Carcinoma | Xp11 Translocation CarcinomaAustralia
-
Olivia Newton-John Cancer Research InstituteAustin Health; Merck Healthcare KGaATerminated
-
Shanghai Henlius BiotechRecruitingNon-small Cell Lung Cancer | Locally Advanced or Metastatic Solid TumorsAustralia
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States, Poland, Greece, Australia, Sweden
-
Peter MacCallum Cancer Centre, AustraliaNovartisActive, not recruitingMantle Cell Lymphoma RecurrentAustralia
-
Peter MacCallum Cancer Centre, AustraliaCompletedHodgkin Lymphoma | Lymphoma, T-Cell, Cutaneous | Lymphoma, T-Cell, PeripheralAustralia
-
SanofiRecruitingPlasma Cell MyelomaGermany, United States, Argentina, China, France, Hong Kong, Italy, Japan, Puerto Rico, Spain, Switzerland, United Arab Emirates, United Kingdom, Austria, Belgium, Netherlands, Taiwan
-
Peter MacCallum Cancer Centre, AustraliaRecruitingRenal Cell Carcinoma, Clear Cell, SomaticAustralia
-
Australian and New Zealand Urogenital and Prostate...RecruitingRenal Cell Carcinoma | Sarcomatoid Renal Cell Carcinoma | Papillary Renal Cell Carcinoma Type 1 | Papillary Renal Cell Carcinoma Type 2 | Chromophobe Renal Cell Carcinoma | Xp11.2 Translocation-Related Renal Cell CarcinomaAustralia
-
CelgeneCelgene CorporationCompletedMultiple Myeloma | Refractory Multiple Myeloma | Multiple Myeloma in RelapseUnited States, Australia
-
Peter MacCallum Cancer Centre, AustraliaHoffmann-La RocheActive, not recruitingDiffuse Large B Cell Lymphoma | High-grade B-cell LymphomaAustralia
-
Barwon HealthPeter MacCallum Cancer Centre, Australia; Deakin UniversityTerminated
-
MorphoSys AGCompletedMultiple MyelomaAustria, Germany
-
AbbVieTerminatedCancer | Multiple Myeloma (MM)United States, Australia, France, Israel, Japan, Spain, Taiwan
-
Queensland HealthMerck Sharp & Dohme LLCRecruitingHead and Neck Cancer | Cutaneous Squamous Cell Carcinoma of the Head and NeckAustralia
-
Hoffmann-La RocheRecruitingMultiple MyelomaKorea, Republic of, Australia, Spain, France, Poland
-
Peter MacCallum Cancer Centre, AustraliaGlaxoSmithKline; Merck Sharp & Dohme LLCTerminatedFollicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone LymphomaAustralia
-
BeiGeneCompletedWaldenström's MacroglobulinemiaUnited States, Spain, Australia, France, United Kingdom, Germany, Netherlands, Czechia, Italy, Poland, Belgium, Greece, Sweden
-
GlaxoSmithKlineCompletedCarcinoma, Renal CellUnited States, Australia
-
AmgenActavis Inc.CompletedNon-small Cell Lung Cancer MetastaticUnited States, Bulgaria, Australia
-
Trans Tasman Radiation Oncology GroupActive, not recruitingRenal Cell CarcinomaAustralia
-
Keythera Pharmaceuticals (Australia) Pty LtdRecruitingGastric Cancer | Colorectal Cancer | Lung Cancer | Bladder Cancer | Advanced Solid Tumor | Squamous Cell Carcinoma of the EsophagusAustralia
-
CRISPR Therapeutics AGActive, not recruitingMultiple MyelomaUnited States, Spain, Australia, Canada
-
Novartis PharmaceuticalsCompletedRelapsed and Refractory Multiple MyelomaItaly, Germany, Singapore, Australia, United States
-
Prothena Biosciences Ltd.TerminatedAL AmyloidosisUnited States, Spain, Australia, Italy, Germany, Austria, Greece, France, Israel, United Kingdom
-
SanofiActive, not recruitingPlasma Cell MyelomaItaly, Korea, Republic of, Norway, Canada, Spain, Germany, Greece, Lithuania, Sweden, Israel, Hungary, France, Japan, Australia, China, Denmark, Czechia, Turkey, United States, Brazil, Ireland, New Zealand, Poland, United Kingdom
-
Novartis PharmaceuticalsCompletedRelapsed or Refractory Multiple MyelomaGermany, Spain, Singapore, United States, Australia
-
Peter MacCallum Cancer Centre, AustraliaCompletedNon-small Cell Lung CancerAustralia, Canada
-
AstraZenecaCompletedNon Small Cell Lung CarcinomaAustralia
-
Melbourne HealthAnHeart Therapeutics Inc.; Walter and Eliza Hall Institute of Medical ResearchActive, not recruiting
-
Clarity Pharmaceuticals LtdActive, not recruitingNeuroendocrine TumorsAustralia
-
Medical University InnsbruckTerminatedHead and Neck NeoplasmsAustria
-
Western Sydney Local Health DistrictUnknown
-
Hoffmann-La RocheRecruitingRelapsed or Refractory Multiple MyelomaKorea, Republic of, Denmark, Spain, Australia, Italy, New Zealand, France, Canada, Germany